ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1344 National Cancer Institute Html en How To Handle Withdrawal Symptoms and Triggers When You Decide To Quit Smoking This fact sheet provides helpful tips related to smoking cessation.
routine smoke breaks0.282965
smoking effects0.278771
relaxation techniques0.313407
nicotine addiction0.355656
Control Research Branch0.30123
Yes. Nicotine replacement0.344131
nicotine withdrawal symptoms0.36823
urge0.354906
tips0.337093
negative feelings0.295635
Nicotine nasal spray0.380205
tea0.279209
Tobacco Control Research0.298555
things0.265705
tobacco smoke0.262113
nicotine replacement therapy0.347084
drinking coffee0.292775
highly dependent smokers0.261935
daily life0.289451
Smoking Quitline0.271985
Step-by-Step Quit Guide0.333256
nicotine replacement products0.922705
help quitting tobacco0.287795
nicotine replacement product0.346885
smoking increase0.274802
weight gain0.385772
smokers0.365077
counter weight gain0.289631
nicotine cravings0.53551
nicotine doses0.315612
common negative feelings0.293918
smoking0.59993
nicotine lozenge0.318321
nicotine inhaler0.328106
nicotine travels0.313333
nicotine level drops0.347286
chews nicotine gum0.341989
people0.407906
strong urge0.298124
physical activity0.320031
people smoking0.295038
nicotine gum0.386182
nicotine patch0.339006
withdrawal symptoms0.655994
common withdrawal symptoms0.360181
coffee0.312007
smoking cessation trials0.292819
Occasional mild cravings0.284899
time0.303672
CLICK HERE
1447 National Cancer Institute Html null Unusual Cancers of Childhood Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of unusual cancers of childhood such as cancers of the head and neck, chest, abdomen, reproductive system, skin, and others.
CLICK HERE
1495 National Cancer Institute Html en Hairy Cell Leukemia Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of hairy cell leukemia.
purine analog therapy0.544174
BRAF inhibitor0.537215
overall response rate0.600065
cell leukemia patients0.629349
purine analogs0.574118
Hot Flashes0.53761
complete remission rate0.547966
long-term follow-up0.53699
long term follow-up0.54098
Tiacci et al.0.545702
Foucar MK0.540256
classic-form hairy cell0.592078
cell leukemia variants.0.563299
peripheral blood counts0.541349
Pettirossi et al.0.546064
median overall survival0.57455
9-year median follow-ups0.545986
patients0.634056
continuous infusion0.540582
multicenter studies0.537514
VH4-34+ hairy cell0.567746
B-cell lymphomas0.539052
Rosenberg et al.0.545728
Natl Cancer Inst0.537773
hairy-cell leukemia0.564359
Night Sweats0.538245
et al.0.547621
median treatment-free survival0.574134
partial remission rate0.543701
stable partial remission0.545722
cladribine0.537399
complete remissions0.537086
one-time continuous infusion0.53916
comparable response rates0.548208
treatment option0.539331
median follow-up0.54766
potential increased risk0.575127
cell leukemia variant0.57205
overall response rate.0.539597
complete response rate0.636139
Abstract0.548918
hairy cell leukemia0.918712
Clin Oncol0.592807
subcutaneous injections0.544059
PDQ summary0.53807
cell leukemia variants0.563543
previously untreated patients0.548389
standardized incidence ratio0.536889
CLICK HERE
1611 National Cancer Institute Html en Late Effects of Treatment for Childhood Cancer (PDQ®)–Health Professional Version Serious, disabling, and life-threatening chronic health conditions adversely affect the health of aging childhood cancer survivors. Learn about the cardiovascular, cognitive, psychosocial, digestive, endocrine, immune, musculoskeletal, reproductive, and urinary late effects and subsequent neoplasms that contribute to a high burden of morbidity in childhood cancer survivors.
adult cancer survivors0.344142
childhood leukemia survivors0.307057
Childhood Cancer Guideline0.302298
childhood cancer therapy0.296791
long-term cancer survivors0.295333
childhood cancer survivors0.499567
Engl J Med0.269755
Br J Cancer0.261959
Cancer Survivor cohort0.269169
Int J Cancer0.266011
Ann Intern Med0.263377
5-year survivors0.295172
cancer survivors research0.286942
Radiat Oncol Biol0.277048
breast cancer surveillance0.269328
adult survivors0.315122
Hudson MM0.309712
young adult cancer0.340977
British Childhood Cancer0.326521
Natl Cancer Inst0.402086
survivor study cohort0.273371
Clin Cancer Res0.263669
Irradiated Childhood Cancer0.298512
childhood cancer0.912384
cancer survivor study0.693286
et al.0.431618
late effects0.3275
long-term survivors0.333244
cohort study0.263432
Cancer Epidemiol Biomarkers0.265429
pediatric cancer survivors0.286679
PUBMED Abstract0.35078
Pediatr Blood Cancer0.447984
radiation-induced breast cancer0.26406
breast cancer risk0.280733
Abstract0.467444
Clin Oncol0.515912
breast cancer0.391476
Oncol Biol Phys0.278259
childhood cancer survivor0.771953
Cancer Guideline Harmonization0.260525
young cancer survivors0.275759
childhood cancer registry0.291062
long-term follow-up guidelines0.273165
Cancer J Clin0.270171
report0.265432
childhood cancer treatment0.287484
oncology group0.32484
long-term childhood cancer0.311378
CLICK HERE
2029 National Cancer Institute Html es Prevención del cáncer de seno (mama) (PDQ®)–Versión para profesionales de salud Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer de mama y sobre las investigaciones dirigidas a la prevención de esta enfermedad.
Sestak I0.314213
Methods Mol Biol0.309681
menor incidencia0.315649
Breast Cancer Surveillance0.32247
largo plazo0.325123
Risk Calculator0.330192
Cuzick J0.314017
breast cancer prevention0.340448
útero intacto0.328063
Estados Unidos0.337849
menor riesgo0.381674
cancer prevention trial0.330827
Women's Health Initiative0.311811
principal factor0.31767
Health Initiative0.316067
from benign breast0.320129
Breast density0.313434
lobular breast0.315708
English record linkage0.310983
hormonas estrógeno0.31642
health study0.316005
benign breast0.353338
Cancer Res Treat0.315355
Cancer Risk Assessment0.316082
Epidemiol Biomarkers Prev0.309854
enfermedad proliferativa benigna0.311069
Goss PE0.314786
antecedentes familiares0.49279
Breast Risk Calculator0.318395
prospective cohort study0.311422
breast cancer risk0.370651
reducción promedio0.315263
breast cancer0.951386
cardiopatía coronaria0.328283
riesgos instantáneos0.314306
IBIS-I breast0.313331
risk factor0.343815
mujeres portadoras0.329041
Cancer Surveillance System0.312955
IBIS Breast Cancer0.320333
heritable risk factor0.311842
Risk Calculator Tool0.311
Reino Unido0.311996
Women’s Health Initiative0.309787
Breast Cancer Referral0.321555
parenchymal patterns as0.309616
Otro estudio0.316688
Breast Cancer Res0.357313
mujeres jóvenes0.346647
CLICK HERE
2052 National Cancer Institute Html es Terapias biológicas para el cáncer Hoja informativa sobre la función del sistema inmunitario; describe la acción de las terapias biológicas.
Haluska FG0.420038
Redig AJ0.419038
ARN mensajero0.423865
killer cell-based immunotherapy0.432963
células hijas0.643617
Canese P0.41842
O'Day SJ0.419485
clinical applications0.420154
we tilt0.419245
immune system0.418755
altas dosis0.418691
linfocitos b0.794775
antígeno cd520.453352
Translational Medicine0.419593
Comité Asesor0.418458
biological therapy0.455134
Internal Medicine0.419677
Estados Unidos0.448833
Expert Opinion0.421046
linfocitos t0.82421
intrusos foráneos0.428976
towards immune-mediated0.419994
PubMed Abstract0.779921
metastatic melanoma0.424461
madre sanas formadoras0.440701
terapia modificadora0.491313
Abeloff's Clinical Oncology0.43296
mARN blanco0.422446
antígeno cd200.515911
bacteria bacilo0.445994
Improved survival with0.436486
invasores foráneos0.480692
células madre0.955075
molécula her-20.428705
Cancer immunology0.420503
Ningún virus0.447968
on tumor immunology0.437409
McDermott DF0.418981
envoltorio protector0.421713
IFN)-dependent activation0.420375
terapia biológica usa0.634008
90Y‑ibritumomab tiuxetán0.424391
ingeniería genética0.421138
sistema inmunitario.  aún0.450887
escasa toxicidad0.422699
biológica usa organismos0.547748
Aún más0.468819
virus vector0.444624
New England Journal0.430623
CLICK HERE
2069 National Cancer Institute Html es Enfermedad de Paget de seno Hoja informativa sobre la enfermedad de Paget de seno, un tipo poco común de cáncer que algunas veces se llama enfermedad de Paget del pezón o enfermedad de Paget de mama.
Lippincott Williams0.227873
Tumor Characteristics0.23784
Eisner MP0.227823
cáncer invasor0.852818
afecciones benignas0.232299
Cody HS0.226638
Female Breast0.245015
posibles tumores0.243494
long-term follow-up study0.244429
Breast Cancer Research0.268606
siglo xix sir0.249073
breast-conserving therapy0.228801
Lippman ME0.226791
ganglios linfáticos centinela0.294176
afección benigna0.309089
SEER Program0.276615
Kanitakis J0.22651
estadio i0.22947
Hasson D0.226314
European Institute0.226377
Keel GE0.226988
PubMed Abstract0.996634
Haffty BG0.225876
clinical presentation0.228015
Therapeutic options0.226841
with radiotherapy0.228051
Tucker SL0.226414
Paget mamaria0.499743
estadio iv0.228625
End Results0.22623
Griffith KA0.226914
signo revelador0.231703
proteína her20.228884
National Cancer Institute0.247867
4th ed0.228822
Sosnovskikh I0.226721
Ries LAG0.280943
edad promedio0.227469
Breast Journal0.241614
Osborne CK0.226941
Sir James Paget0.694935
Cancer Survival Among0.251885
estadio iii0.228362
Gatti G0.22751
Retrieved April0.227819
sentinel lymph0.278815
European Academy0.22756
extramammary paget0.443981
Dimaio DJ0.226799
CLICK HERE
2972 National Cancer Institute Video en Reach out and offer her a helping hand: A Smokefree Pregnancy Video We know quitting smoking is tough, and becoming pregnant doesn't suddenly make it easier. "Reach Out & Offer Her a Helping Hand" is intended to rally the American public's support for all mamas-to-be trying to put out the cigs. For more info on how you can help that special lady in your life quit smoking for good, visit: women.smokefree.gov
SmokefreeWomen0.826013
Healthier Summer Sweets0.545266
040.327172
women.smokefree.gov0.329
NCI Smokefree0.680659
Good Night0.430291
Positive Environment0.433577
life0.329079
NCI Smokefree Pregnancy0.635056
Challenge0.408491
Motivator0.335402
American public0.460348
smoking0.356739
smoke smell0.447387
Smokefree Voices Video0.623419
Contest0.32649
How-to Video0.421251
Blog0.32681
views0.825633
busy schedule0.430343
info0.329188
Helping Hand0.601743
Reach0.325318
Smokefree Women0.817171
Voiceover0.330521
Duration0.991806
autoplay0.374808
NCI Smokefree Women0.669737
De-stress0.333641
special lady0.458682
Offer0.359013
Street Team Video0.555716
Clean house0.432823
newest video0.459372
Fitting fitness0.42414
visit0.325778
cigs0.329305
support0.329395
Healthy Body Image0.533317
CLICK HERE
14601 National Cancer Institute Html en Childhood Vascular Tumors Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of childhood vascular tumors.
lesions0.459907
body0.444762
PDQ cancer information0.428885
steroid therapy0.431929
malignant tumors0.409372
clinical trials0.622735
aggressive vascular tumors0.43708
congenital hemangioma0.425723
cancer information summary0.40263
Diagnostic Tests0.677407
liver0.469914
lobular capillary hemangioma0.410892
blood vessels0.494734
pyogenic granuloma0.401485
diffuse tumors0.399482
benign vascular tumor0.531292
vascular tumors0.851122
clinical trial0.485314
spindle cell hemangiomas0.4591
malignant vascular tumors0.461238
radiation therapy0.585507
following0.416254
late effects0.40785
General Information section0.953371
treatment0.883924
blood vessel0.40513
childhood vascular tumor0.423751
skin0.519128
vascular tumor0.671886
benign vascular tumors0.586046
infantile hemangiomas0.495631
signs0.415044
treatment clinical trials0.412572
procedures0.39986
multiple lesions0.412762
tumor cells0.435841
new treatment0.424941
topical beta-blocker therapy0.421578
kaposiform hemangioendothelioma0.442163
hemangiomas0.524006
risk factor0.415027
childhood vascular tumors0.50237
benign tumors0.412061
blood vessel tumors0.39943
kaposi sarcoma0.437901
standard treatment0.431582
diffuse liver tumors0.410968
surgery0.449251
CLICK HERE
16840 National Cancer Institute Html en Companies Formed by PIs of the NCI Alliance for Nanotechnology in Cancer The NCI Alliance for Nanotechnology in Cancer has continued to translate solutions from the bench to products. Find out the companies that have been formed by Alliance funded research.
clinical products0.627038
Alliance members0.614849
academic laboratories0.654334
for-profit partners0.714957
start-ups0.300298
clinical communities0.60175
venture capital funds0.950483
investigators0.301645
partnerships0.289977
start-up companies0.650807
patents0.29414
large pharmaceutical companies0.926075
translational research0.68727
significant investment0.618191
Alliance PIs0.780886
efficient development0.679103
IP0.327964
Alliance model0.651092
services0.276826
start-up companies.0.723832
technologies0.28746
biotechnology firms0.63767
form0.28731
discoveries0.300415
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.